Also categorized in Global Health:
Cannabis-Based Drug for Epilepsy to Be Fast-Tracked Into NHS
x hide permanently

New Vaccine Formulation Protects Newborn Mice Against Respiratory Syncytial Virus (RSV)

Medical Xpress

Photo: CDC/ Dr. Erskine Palmer / Public Domain

MedicalXpress.com

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

RSV is a leading cause of infant hospitalizations in the U.S. and is also a threat in older adults. While several potential RSV vaccines are in ...